数学建模和药物治疗方案的优化用于乳腺癌组合免疫疗法
Zixiao Xiong1, Yunfei Xia1, Ling Xue2
1College of Mathematical Sciences, Harbin Engineering University, Harbin, 150001, Heilongjiang, China.
Bulletin of mathematical biology
|June 2, 2025
概括
这项研究通过模拟mRNA疫苗和抗CTLA-4抗体来优化癌症治疗. 数学模拟表明,在接种疫苗后给予抗CTLA-4抗体可以提高疗效并最大限度地减少副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 免疫疗法,包括mRNA癌症疫苗,通过激活T细胞在癌症治疗中显示出前景.
- 细胞毒性T淋巴细胞抗原4 (CTLA-4) 信号抑制T细胞激活,可能降低mRNA疫苗的有效性.
- 抗CTLA-4抗体疗法可以阻止这种抑制,但可能导致免疫毒性副作用,需要优化治疗方案.
研究的目的:
- 开发一种数学模型,模拟瘤免疫微环境中的mRNA癌症疫苗和抗CTLA-4抗体的联合作用.
- 使用计算方法优化药物治疗方案,以改善瘤抑制和减少副作用.
- 为在临床环境中选择有效和安全的癌症治疗策略提供理论框架.
主要方法:
- 开发一个数学模型来表示mRNA疫苗和抗CTLA-4抗体之间的相互作用.
- 通过马尔科夫链蒙特卡洛 (MCMC) 模拟使用实验数据对模型进行参数化.
- 应用梯度下降方法来优化药物给药时间表和剂量.
主要成果:
- 模型模拟表明与实验数据一致,验证了数学方法.
- 优化方案表明,抗CTLA-4抗体的注射应在mRNA疫苗接种后进行.
- 在安全范围内,抗CTLA-4抗体剂量与疫苗剂量之间的正相关性被认为是有益的.
结论:
- 这项研究为优化组合免疫疗法方案提供了数学基础.
- 与mRNA疫苗相对抗CTLA-4抗体的时间和剂量对于最大限度地提高治疗效益和最大限度地降低毒性至关重要.
- 这项研究为设计未来癌症免疫治疗临床试验提供了宝贵的见解.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Drug Dosage Regimen: Overview
3.9K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.9K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Pharmacokinetic Models: Comparison and Selection Criterion
155
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
155
Three-Compartment Open Model
461
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
461


